Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 19,746	$ 32,019
Accounts receivable, net	10,791	3,569
Inventory, net	6,466	3,368
Prepaid expenses and other current assets	2,310	4,136
Total current assets	39,313	43,092
Property and equipment, net	4,202	4,230
Goodwill	2,715	2,715
BELBUCA®license and distribution rights intangible	41,625
Other intangible assets, net	1,558	2,285
Total assets	89,413	52,322
Current liabilities:
Accounts payable and accrued liabilities	30,807	18,174
Deferred revenue, current		1,716
Total current liabilities	30,807	19,890
Notes payable, net of discount and loan costs	35,701	29,272
Deferred revenue, long-term		20,000
Other long-term liabilities	4,050	825
Total liabilities	70,558	69,987
Commitments and contingencies (Notes 11 and 16)
Stockholders' equity:
Preferred Stock, $.001 par value; 5,000,000 shares authorized; 2,093,155 shares of Series A Non-Voting Convertible Preferred Stock outstanding at both September 30, 2017 and December 31, 2016, respectively.	2	2
Common Stock, $.001 par value; 75,000,000 shares authorized; 55,852,926 and 54,133,511 shares issued; 55,837,435 and 54,118,020 shares outstanding at September 30, 2017 and December 31, 2016, respectively.	56	54
Additional paid-in capital	307,690	292,667
Treasury stock, at cost, 15,491 shares	(47)	(47)
Accumulated deficit	(288,846)	(310,341)
Total stockholders' equity (deficit)	18,855	(17,665)
Total liabilities and stockholders' equity (deficit)	$ 89,413	$ 52,322